Related Experiment Video
Updated: May 13, 2026

23:06
The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
Published on: August 11, 2008
[Response to therapy in multiple drug resistant tuberculosis patients]
Mercedes de la Paz García de la Osa1, Eberto García Silvera, Mercedes Solano Leal
1Hospital Neumológico "Benéfico Jurídico", La Habana, Cuba. mercedes.delapaz@infomed.sld.cu
Revista Cubana De Medicina Tropical
|March 1, 2013
Summary
Individualized treatment under direct observation for multiple drug-resistant tuberculosis (MDR-TB) showed effectiveness in over half of non-HIV patients. This approach offers a viable strategy for managing this complex and challenging infectious disease.
Area of Science:
- Infectious Diseases
- Pulmonology
- Microbiology
Context:
- Multiple drug-resistant tuberculosis (MDR-TB) presents a significant global health challenge.
- Treatment of MDR-TB requires specialized, often prolonged, and more toxic drug regimens.
- Non-HIV seropositive patients represent a distinct cohort with specific treatment considerations.
Purpose:
- To evaluate the effectiveness of individualized treatment strategies for patients with MDR-TB.
- To assess treatment response in non-HIV seropositive individuals undergoing MDR-TB therapy.
- To analyze treatment outcomes based on patient categories and treatment failures.
Summary:
- A descriptive study of 42 non-HIV MDR-TB patients treated over ten years with individualized, directly observed therapy.
- Bacteriological conversion occurred at an average of 4.6 months (direct exam) and 6 months (culture).
- The highest cure rates were observed in chronically ill patients (23.8%) and those classified as treatment failures (21.4%).
Impact:
- Individualized, directly observed treatment for MDR-TB demonstrates effectiveness in over 50% of cases.
- Findings suggest tailored treatment regimens can improve outcomes in challenging MDR-TB populations.
- This study contributes evidence supporting optimized therapeutic approaches for drug-resistant tuberculosis.
Related Concept Videos
Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
